Total Funding
51
68
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
24054
Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases
- Paul Chu: Vice President Business Development
- Ming Wang: Founder, President and CEO
About the Company
Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases. Their extensive experience and deep scientific knowledge strongly position us to discover and advance robust therapeutic molecules. Through scientific innovation, we deliver better treatment options for patients. Their
mission is to relentlessly seek scientific and technological solutions to improve the lives of patients globally.
